Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs

Epilepsy and Behavior

Volumn 21, Issue 4, 2011, Pages 453-458

  Pack, Alison M ^a   Morrell, Martha J ^b   McMahon, Don J ^a   Shane, Elizabeth ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Epilepsy; Estradiol; Vitamin D

Indexed keywords

ANTICONVULSIVE AGENT; BIOLOGICAL MARKER; CALCIUM; CARBAMAZEPINE; ESTRADIOL; LAMOTRIGINE; PHENYTOIN; SEX HORMONE BINDING GLOBULIN; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM BONE LEVEL; EPILEPSY; ESTRADIOL BLOOD LEVEL; FEMALE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOLYSIS; SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D BLOOD LEVEL;

ADOLESCENT; ADULT; ANTICONVULSANTS; BONE DENSITY; CARBAMAZEPINE; EPILEPSY; ESTRADIOL; FEMALE; HUMANS; PHENYTOIN; TRIAZINES; VITAMIN D;

EID: 80051472061     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2011.05.001     Document Type: Article

References (32)

1. Souverein P.C., Webb D.J., Weil J.G., Van Staa T.P., Egberts A.C. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology 2006, 66:1318-1324.
2. Souverein P.C., Webb D.J., Petri H., Weil J., Van Staa T.P., Egberts T. Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia 2005, 46:304-310.
3. Sheth R.D., Gidal B.E., Hermann B.P. Pathological fractures in epilepsy. Epilepsy Behav 2006, 9:601-605.
4. Cummings S.R., Nevitt M.C., Browner W.S., et al. Risk factors for hip fracture in white women. N Engl J Med 1995, 332:767-773. for the Study of Osteoporotic Fractures Research Group.
5. Vestergaard P. Epilepsy, osteoporosis and fracture risk: a meta-analysis. Acta Neurol Scand 2005, 112:277-286.
6. Pack A.M., Morrell M.J., Marcus R., et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005, 57:252-257.
7. Stephen L.J., McLellan A.R., Harrison J.H., et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 1999, 8:339-342.
8. Verrotti A., Greco R., Morgese G., Chiarelli F. Increased bone turnover in epileptic patients treated with carbamazepine. Ann Neurol 2000, 47:385-388.
9. Verrotti A., Greco R., Latini G., Morgese G., Chiarelli F. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia 2002, 43:1488-1492.
10. Verrotti A., Coppola G., Parisi P., Mohn A., Chiarelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg 2010, 112:1-10.
11. Pack A.M., Walczak T.S. Bone health in women with epilepsy: clinical features and potential mechanisms. Int Rev Neurobiol 2008, 83:305-328.
12. Khosla S. Update in male osteoporosis. J Clin Endocrinol Metab 2010, 95:3-10.
13. Khosla S. Update on estrogens and the skeleton. J Clin Endocrinol Metab 2010, 95:3569-3577.
14. Lee A.J., Cai M.X., Thomas P.E., Conney A.H., Zhu B.T. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003, 144:3382-3398.
15. Van Cromphaut S.J., Rummens K., Stockmans I., et al. Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res 2003, 18:1725-1736.
16. Kawano N., Koji T., Hishikawa Y., Murase K., Murata I., Kohno S. Identification and localization of estrogen receptor alpha- and beta-positive cells in adult male and female mouse intestine at various estrogen levels. Histochem Cell Biol 2004, 121:399-405.
17. Tsuchiya Y., Nakajima M., Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005, 227:115-124.
18. Herzog A.G., Coleman A.E., Jacobs A.R., et al. Interictal EEG discharges, reproductive hormones, and menstrual disorders in epilepsy. Ann Neurol 2003, 54:625-637.
19. Murialdo G., Galimberti C.A., Gianelli M.V., et al. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998, 21:52-58.
20. Morrell M.J., Flynn K.L., Seale C.G., et al. Reproductive dysfunction in women with epilepsy: antiepileptic drug effects on sex-steroid hormones. CNS Spectr 2001, 6(771-2):83-86.
21. Burakgazi E., Harden C., Kelly J.J. Contraception for women with epilepsy. Rev Neurol Dis 2009, 6:E62-E67.
22. Pack A.M., Morrell M.J., Randall A., McMahon D.J., Shane E. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 2008, 70:1586-1593.
23. Morrell M.J., Giudice L., Flynn K.L., et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002, 52:704-711.
24. Block G., Hartman A.M., Dresser C.M., Carroll M.D., Gannon J., Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986, 124:453-469.
25. Katzman D.K., Bachrach L.K., Carter D.R., Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991, 73:1332-1339.
26. Sodergard R., Backstrom T., Shanbhag V., Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982, 16:801-810.
27. Desai M.P., Bhanuprakash K.V., Khatkhatay M.I., Donde U.M. Age-related changes in bone turnover markers and ovarian hormones in premenopausal and postmenopausal Indian women. J Clin Lab Anal 2007, 21:55-60.
28. Sowers M.R., Jannausch M., McConnell D., et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006, 91:1261-1267.
29. Sowers M.R., Finkelstein J.S., Ettinger B., et al. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int 2003, 14:44-52.
30. Bjornerem A., Emaus N., Berntsen G.K., et al. Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromso study. Calcif Tissue Int 2007, 81:65-72.
31. Hoppe E., Bouvard B., Royer M., Audran M., Legrand E. Sex hormone-binding globulin in osteoporosis. Joint Bone Spine 2010, 77:306-312.
32. Verrotti A., D'Egidio C., Coppola G., Parisi P., Chiarelli F. Epilepsy, sex hormones and antiepileptic drugs in female patients. Expert Rev Neurother 2009, 9:1803-1814.